Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 5/20 | 0.59 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.53 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.52 |
| ▸ | TBXAS1 | P24557 | 6/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28245984 | 0.98 | FDPS (0.57) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 | |
| Hydrochloric Acid SCHEMBL8504424 | 0.98 | FDPS (0.57) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8505453 | 0.92 | FDPS (0.52) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL11068494 | 0.89 | TBXAS1 (0.58) | FDPSNAPRTRIPK1TBXAS1 | |
| Hydrochloric Acid SCHEMBL11066261 | 0.88 | TBXAS1 (0.59) | FDPSNAPRTRIPK1TBXAS1 | |
| SCHEMBL27457037 | 0.86 | CYP1A2 (0.54) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL25260235 | 0.83 | FDPS (0.56) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL30969130 | 0.83 | FDPS (0.56) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL8506198 | 0.83 | FDPS (0.55) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 | |
| SCHEMBL25260237 | 0.83 | FDPS (0.56) | FDPSNAPRTCYP1A2CYP3A4CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0730598-B1 | HINDERED ESTERS OF RAPAMYCIN AND THEIR USE AS PHARMACEUTICALS | AMERICAN HOME PROD (US) | 1999-06-09 | — | — | EP | claimed |
| EP-0730598-A1 | HINDERED ESTERS OF RAPAMYCIN AND THEIR USE AS PHARMACEUTICALS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-09-11 | — | — | EP | claimed |
| WO-1995014696-A1 | HINDERED ESTERS OF RAPAMYCIN AND THEIR USE AS PHARMACEUTICALS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-06-01 | — | — | WO | claimed |
| US-5385908-A | Hindered esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-01-31 | — | — | US | claimed |
| CN-110790809-B | Preparation method of abiraterone acetate | 奥锐特药业股份有限公司 | 2021-04-02 | — | — | CN | disclosed |
| US-20170152443-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | CHI MEI CORPORATION (TW) | 2017-06-01 | — | — | US | disclosed |
| US-20170152443-A1 | LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT | CHI MEI CORPORATION (TW) | 2017-06-01 | — | — | US | disclosed |
| CN-103429598-A | Organozinc complexes and methods of making and using the same | UNIV MUENCHEN L MAXIMILIANS | 2013-12-04 | — | — | CN | disclosed |
| EP-0794955-B1 | HINDERED N-OXIDE ESTERS OF RAPAMYCIN AND THEIR USE AS MEDICAMENTS | AMERICAN HOME PROD (US) | 2001-07-25 | — | — | EP | disclosed |
| EP-0730598-B1 | HINDERED ESTERS OF RAPAMYCIN AND THEIR USE AS PHARMACEUTICALS | AMERICAN HOME PROD (US) | 1999-06-09 | — | — | EP | disclosed |
| EP-0794955-A1 | HINDERED N-OXIDE ESTERS OF RAPAMYCIN AND THEIR USE AS MEDICAMENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1997-09-17 | — | — | EP | disclosed |
| US-5559122-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-09-24 | — | — | US | disclosed |
| EP-0730598-A1 | HINDERED ESTERS OF RAPAMYCIN AND THEIR USE AS PHARMACEUTICALS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-09-11 | — | — | EP | disclosed |
| WO-1996016967-A1 | HINDERED N-OXIDE ESTERS OF RAPAMYCIN AND THEIR USE AS MEDICAMENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-06-06 | — | — | WO | disclosed |
| US-5521194-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-05-28 | — | — | US | disclosed |
| US-5508285-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-04-16 | — | — | US | disclosed |
| US-5508290-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-04-16 | — | — | US | disclosed |
| US-5491231-A | Hindered N-oxide esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-02-13 | — | — | US | disclosed |
| WO-1995014696-A1 | HINDERED ESTERS OF RAPAMYCIN AND THEIR USE AS PHARMACEUTICALS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-06-01 | — | — | WO | disclosed |
| US-5385908-A | Hindered esters of rapamycin | AMERICAN HOME PRODUCTS CORPORATION (US) | 1995-01-31 | — | — | US | disclosed |